Arrhythmias/Electrophysiology
Observational study suggests Apixaban for AF is associated with a lower risk of GI bleeding vs. other DOACs.
3 Nov, 2022 | 13:32h | UTCComparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation: A Multinational Population-Based Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
News Release: Best blood thinner for minimizing bleeding risk identified – University College London
Commentary: GI Bleeding Lower With Apixaban Versus Other DOACs in A-Fib – HealthDay
M-A | The success rate of cardioversion for AF was similar between anterior-posterior vs. anterior-lateral electrodes position.
1 Nov, 2022 | 12:09h | UTC
RCT | Pulmonary vein isolation plus individualized substrate ablation of atrial low-voltage myocardium reduced A-fib recurrence.
28 Oct, 2022 | 13:24h | UTCLow-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation – NEJM Evidence
Commentary on Twitter
Original Article: “Low-Voltage Myocardium-Guided Ablation Trial of Persistent Atrial Fibrillation,” by @YanHuo2022 et al. https://t.co/OYqzAt7ks0#CardioTwitter #AFib #MedTwitter @tudresden_de @ThomasGaspar16 @purerfellner @EPyoungstar @UKSH_KI_HL @MedUni_Wien @KardiologieWien pic.twitter.com/0ly3pjNiPa
— NEJM Evidence (@NEJMEvidence) October 24, 2022
Cohort Study | Cannabis, cocaine, methamphetamine, and opiates linked to increased risk of incident atrial fibrillation.
27 Oct, 2022 | 12:29h | UTCEditorial: Drug abuse and risk of atrial fibrillation: a neglected association – European Heart Journal
Commentaries:
Marijuana, Meth, Cocaine Use Can Help Trigger Dangerous A-Fib – HealthDay
Commentary on Twitter
New study just published in EHJ suggests that cannabis, cocaine, methamphetamine, and opiates may increase the risk of incident atrial fibrillation: discover more!https://t.co/ySrmaLnacC#AF #methamphetamine #cocaine #opiate #cannabis #cardiotwitter @escardio @ESC_Journals pic.twitter.com/YCvqjPGQjG
— EHJ Editor-in-Chief (@ehj_ed) October 20, 2022
Cohort Study | Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy.
24 Oct, 2022 | 14:08h | UTCEditorial: Arrhythmogenic cardiomyopathies in children: seek and you shall find – European Heart Journal
Commentary on Twitter
Highly malignant disease in childhood-onset arrhythmogenic right ventricular cardiomyopathy: discover more in EHJ!https://t.co/kA60A1zjRt#ARVC #children #screening #heart #transplantation #cardiotwitter @escardio @ESC_Journals pic.twitter.com/fq4X8doBMI
— EHJ Editor-in-Chief (@ehj_ed) September 6, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ License
Cohort Study | Intravenous potassium and magnesium linked to spontaneous conversion of atrial fibrillation in the ED.
20 Oct, 2022 | 12:27h | UTC
Commentary on Twitter
IV potassium and magnesium was associated with higher rates of conversion in atrial fibrillation but not flutter during patients’ emergency department stays. https://t.co/p3nQK8zNMs
— JAMA Network Open (@JAMANetworkOpen) October 19, 2022
Cohort Study | BMI in adolescence and long‐term risk of AF and subsequent mortality, heart failure, and ischemic stroke.
20 Oct, 2022 | 12:20h | UTC
Cohort Study | Visit-to-visit SBP variability linked to increased risk of atrial fibrillation in middle-aged and older populations.
17 Oct, 2022 | 12:30h | UTC
Case series and systematic review | Life-threatening cardiac arrhythmia and sudden death during electronic gaming.
13 Oct, 2022 | 13:49h | UTCEditorial: Ventricular arrhythmias during electronic gaming: Sudden victory and sudden death – Heart Rhythm
News Release: Electronic gaming can trigger potentially lethal heart rhythm problems in susceptible children – Elsevier
Expert Consensus | Screening, diagnosis and follow-up of Brugada syndrome in children.
13 Oct, 2022 | 13:47h | UTC
Brief Review | Atrial fibrillation: rate control or rhythm control?
5 Oct, 2022 | 13:50h | UTCAtrial fibrillation: Rate control or rhythm control? – Cleveland Clinic Journal of Medicine
Evaluation of an ambulatory ECG analysis platform using deep neural networks in routine clinical practice.
20 Sep, 2022 | 13:14h | UTC
Commentary on Twitter
An AI-based Holter ECG analysis strategy saves time and performs similarly compared with a conventional approach @EloiMarijon #AHAJournals https://t.co/lK7h0po4xj
— JAHA (@JAHA_AHA) September 15, 2022
AHA Scientific Statement | Management of patients at risk for and with left ventricular thrombus.
16 Sep, 2022 | 13:00h | UTC
Early versus delayed non–vitamin k antagonist oral anticoagulant therapy after acute ischemic stroke in atrial fibrillation: a registry-based randomized controlled noninferiority study.
8 Sep, 2022 | 14:46h | UTCEarly Versus Delayed Non–Vitamin K Antagonist Oral Anticoagulant Therapy After Acute Ischemic Stroke in Atrial Fibrillation (TIMING): A Registry-Based Randomized Controlled Noninferiority Study – Circulation (free for a limited period)
Commentary on Twitter
Congrats to my good friend/colleague @BoNorrving for the TIMING study! Starting NOAC after stroke d/t AF <4 d is safe (no ICH) and = or better than 5-10 d. Registry-based, pragmatic, investigator led, PROBE design. High value = science first approach.
https://t.co/35qiZ5Ivoa— Dr. Lee Schwamm (@Braindoc_MGH) September 7, 2022
Predictive role of atrial fibrillation in cognitive decline: a systematic review and meta-analysis of 2.8 million individuals.
7 Sep, 2022 | 12:30h | UTC
Commentary on Twitter (thread – click for more)
AF associated with ⬆️ risk of cognitive impairment ?
? HR 1.39 general ?
? HR 2.70 post-stroke ?@natale_md @TJaredBunch @Dr_Santangeli @JonPicciniSr @DrMarthaGulati @rafavidalperez @DhirajGuptaBHRS @SABOURETCardio @iamritu @Hragy @mmamas1973 @SeguraCardio @cpgale3 #afib pic.twitter.com/dZxkd7G1wc— Raviele Antonio (@drraviele) January 21, 2022
Under a https://creativecommons.org/licenses/by/4.0/ license
Cohort Study | Habitual alcohol intake and risk of atrial fibrillation in young adults.
5 Sep, 2022 | 14:33h | UTCHabitual Alcohol Intake and Risk of Atrial Fibrillation in Young Adults in Korea – JAMA Network Open
Invited Commentary: Self-reported Alcohol Consumption and Risk of Atrial Fibrillation – JAMA Network Open
#ESCCongress – RCT | In patients with rheumatic heart disease–associated atrial fibrillation, treatment with a Vitamin K antagonist led to a lower rate of cardiovascular events or death compared to Rivaroxaban.
29 Aug, 2022 | 12:33h | UTCRivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Trial backs standard of care for rheumatic heart disease and atrial fibrillation – European Society of Cardiology
Commentary: INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF – TCTMD
Commentary on Twitter
INVICTUS: In patients with RHD-associated AF, compared to rivaroxaban, VKA reduced cardiovascular events and mortality without increasing bleeding. #ESCCongress https://t.co/4C45LmmB5o pic.twitter.com/9n3OelzZvp
— NEJM (@NEJM) August 28, 2022
#ESCCongress | 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
29 Aug, 2022 | 12:21h | UTCNews Release: People of all ages should learn cardiopulmonary resuscitation – European Society of Cardiology
#ESCCongress – Single-arm study | Efficacy and safety of an extravascular implantable cardioverter–defibrillator.
29 Aug, 2022 | 12:09h | UTCEfficacy and Safety of an Extravascular Implantable Cardioverter–Defibrillator – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary on Twitter
EV ICD: Extravascular ICD can be implanted safely and can detect and terminate induced ventricular arrhythmias at the time of implant. #ESCCongress https://t.co/Th9evkPcIu pic.twitter.com/qWEcM8MggT
— NEJM (@NEJM) August 28, 2022
Secondary analysis of a RCT | Early rhythm control in patients with atrial fibrillation and high comorbidity burden.
24 Aug, 2022 | 14:11h | UTCEarly Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden – Circulation
Commentary on Twitter
#OriginalResearch: In #EAST_AFNET4, substudy of patients w/ CHA2DS2VASC4 >=4 had decreased composite efficacy outcome of lower CV death, CVA or HF/ACS hospitalization w/ rhythm control, but not in patients with lower como… @AndreasRillig @AndreasMetzner7 https://t.co/izES0WodVQ pic.twitter.com/DVyfWsUsOx
— Circulation (@CircAHA) August 17, 2022
Review | Left atrial appendage occlusion, a misnomer?
22 Aug, 2022 | 12:01h | UTCLeft Atrial Appendage Occlusion, A Misnomer? – Mayo Clinic Proceedings
Review | Why is my patient still in sinus tachycardia?
17 Aug, 2022 | 14:06h | UTCWhy Is My Patient Still In Sinus Tachycardia? – emDocs
Cohort Study | Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation.
15 Aug, 2022 | 11:38h | UTCCommentary: ‘Obesity Paradox’ in Atrial Fibrillation Challenged as Mortality Climbs With BMI – Medscape (free registration required)
Commentary from the author on Twitter (thread – click for more)
?? Really excited about our new paper out in @Open_HeartBMJ
Using the @GARFIELD_reg of newly diagnosed AF patients (n=40,482), we examine the association between height/BMI and risk of AF outcomes. https://t.co/lMDCzDsfHw@TRI_Thrombosis
— Fielder Camm (@cfcamm) August 8, 2022
EHRA expert consensus statement on arrhythmic mitral valve prolapse and mitral annular disjunction complex.
12 Aug, 2022 | 14:48h | UTC
Cohort Study | Age at menopause and risk of heart failure and atrial fibrillation.
5 Aug, 2022 | 14:38h | UTCAge at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study – European Heart Journal (link to abstract – $ for full-text)
Editorial: Premature menopause and cardiovascular disease: can we blame estrogen? – European Heart Journal
News Release: Premature menopause is associated with increased risk of heart problems – European Society of Cardiology